Navigation Links
Pharmacyclics Reports Third Quarter 2013 Results
Date:11/7/2013

agent. Enrollment in stage I of dosing cohorts 1-4 is complete with a total of 67 patients enrolled. At this time, an expansion of cohorts 1 and 2 is not planned due to the fact that the protocol-defined response rate was not achieved. Dosing of the enrolled patients in cohorts 3 and 4 is continuing.
  • PCYC-1119: Phase I/IIb study of ibrutinib in combination with carlfizomib in patients with R/R MM was registered in the third quarter of 2013. The Phase I portion of this study is a dose escalation study designed to the safety and recommended Phase IIb dose of ibrutinib and carlfizomib. The Phase IIb portion will be a randomized, double-blind, placebo controlled study to evaluate the efficacy of ibrutinib and carlfizomib versus carlfizomib and placebo. The primary endpoint of the Phase IIb portion of the study is progression-free survival. Pharmacyclics plans to enroll up to 176 patients.
  • Conference CallThe Company will hold a conference call today at 4:30 p.m. ET. To participate in the conference call, please dial 1-877-303-7908 for domestic callers and 1-678-373-0875 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to http://ir.pharmacyclics.com/events.cfm. To access a replay of the call please dial 1-855-859-2056 domestic callers and 1-404-537-3406 for international callers and use the conference ID number: 92632034.  The archived version of the webcast and conference call will be available for 30 days on the Investor Relations section of the Company's Web site at http://www.pharmacyclics.com.

    About ibrutinibB-cells are the immune cells in the body that are responsible for producing antibodies to fight infections and provide long term immunity. Ibrutinib is a B-cell receptor pathway inhibitor that interferes with the proteins involved in signaling and it effectively blocks signals tha
    '/>"/>

    SOURCE Pharmacyclics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine technology :

    1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
    2. Pharmacyclics Reports Second Quarter 2013 Results
    3. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    4. Pharmacyclics Reports First Quarter 2013 Results
    5. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    6. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    7. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    8. Pharmacyclics, Inc. Prices Public Offering of Common Stock
    9. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
    10. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
    11. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/4/2015)... , March 4, 2015 Aethlon Medical, Inc. ... address infectious diseases and cancer, today announced that ... to present a corporate overview at the 27th Annual ... Hotel in Laguna Niguel, California . ... ( http://www.roth.com/main/page.aspx?PageID=7207 ). A live webcast of ...
    (Date:3/4/2015)... , March 4, 2015  Students from Indiana University ... how new medicines are discovered. Through a partnership with ... medical students from IU School of Medicine are learning ... at Lilly play different and important roles in bringing ... a former medical educator, scientific investigator, and health system ...
    (Date:3/4/2015)... LAKE CITY , March 4, 2015  ECR ... VAR ) is showcasing a full spectrum of ... improve image quality, reduce costs, and enable greater patient ... cone-beam CT imaging systems.  These solutions are on display ... in Vienna, Austria this week.   ...
    Breaking Medicine Technology:Aethlon Medical to Present at the 27th Annual ROTH Conference 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 2Lilly and IU School of Medicine Partner on Rotation Program for Medical Students 3Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
    ... 6, 2012 The American Veterinary Medical Association (AVMA) ... of cephalosporins in food animals appears consistent with the ... drug use, but warned against further restrictions not backed ... drug used in livestock, poultry and other food-producing animals, ...
    ... 6, 2012   RetireSafe , a 400,000-supporter ... of America,s seniors on issues regarding Social Security, Medicare, ... (ESI) to return to the negotiating table, and come ... patients whose pharmacy benefit plans are managed by Express ...
    Cached Medicine Technology:AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals 2RetireSafe Urges Express Scripts to Resume Contract Negotiations with Walgreens 2
    (Date:3/4/2015)... 04, 2015 The ability of ... density assessment and help improve breast cancer risk ... accepted for presentation at the European Congress of ... abstracts - eight posters and 2 session presentations ... breast density and quantitative breast imaging software tools ...
    (Date:3/4/2015)... Surrey, BC (PRWEB) March 04, 2015 ... will perform LASIK and PRK procedures at their new ... Vision Correction, Dr. Joseph King and Dr. Gabriel Chu ... ophthalmology practice in Surrey is named Fraser Valley Cataract ... facility is accredited by the College of Physicians and ...
    (Date:3/4/2015)... State officials have awarded $82,500 to ... Public Health at Georgia State University, to support the ... Georgia’s Division of Family and Children Services (DFCS) as ... Center. , The 1-800-CHILDREN Helpline is a top ... referral services that promote the wellbeing of children while ...
    (Date:3/4/2015)... 04, 2015 Organic Valley, the nation’s largest ... announced its cause campaign to Save the Bros, http://savethebros.com/ ... making a difference to Bros everywhere. To date, the ... Facebook. The video was named Adweek’s best commercial of ... Mashable and Digiday, among other media outlets. , “We ...
    (Date:3/4/2015)... PEACHTREE CITY, GA (PRWEB) March 04, 2015 ... their exclusive advanced microfiber technology and their first compression ... the huge success of this collection, SIGVARIS USA is ... in the MIDTOWN MICROFIBER product line. , Constructed from ... designed with all-day comfort in mind. These socks and ...
    Breaking Medicine News(10 mins):Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:King LASIK relocates to Surrey, British Columbia 2Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2
    ... George Abercrombie, president and,chief executive officer, ... leaders at the National Association of Corporate,Directors-Southern ... tell them,that the threat of a pandemic ... with traditional emergency preparedness plans., "While ...
    ... to develop the lung artery disorder, study shows , , WEDNESDAY, ... likely to develop a debilitating and potentially lethal lung disorder ... hypertension is caused by high blood pressure in the arteries ... the condition can become tired, dizzy and short of breath, ...
    ... Steven ,Cojo, Cojocaru forms Team Cojo to fight ... by his own life-saving,kidney transplant, fashion critic and ... to help the 12.5 million people,worldwide affected by ... of the world,s most common, life-threatening genetic,diseases, affecting ...
    ... gear up for the Thanksgiving holiday, a new research ... ( http://www.fasebj.org ), may provide some relief for those ... report, researchers describe a discovery that may allow some ... losing weight: they make a common antioxidant, melanin, in ...
    ... COLUMBIA, Mo. Health Literacy Month, recognized in ... understandable health information. According to the National Assessment ... have proficient health literacy - skills needed to ... populations is the focus of an ongoing study ...
    ... October 29, 2008 Shire plc (LSE: SHP, NASDAQ: ... from a 13-hour analog classroom study in school-aged children ... Disorder (ADHD). In this study, researchers found that ... measured (1.5 hours) through the last time point assessed ...
    Cached Medicine News:Health News:CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans 2Health News:CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans 3Health News:Women at Higher Risk for Pulmonary Hypertension 2Health News:Cojo to Hit the Streets of LA for 2008 Walk for PKD 2Health News:New drug target in obesity: Fat cells make lots of melanin 2Health News:$8.6 million grant to MU will fund efforts to improve health literacy, health outcomes 2Health News:VYVANSE provided behavior, inattention and math test score improvements in children with ADHD 2Health News:VYVANSE provided behavior, inattention and math test score improvements in children with ADHD 3
    PremierEdge™ MVR Knives. Angled....
    VISCO SHIELD Viscoelastic. Complete with 23g x 7/8" Thin Wall Cannula....
    Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
    Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
    Medicine Products: